Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C2 | P08235 | 6/20 | 0.54 |
| ▸ | AVPR2 | P30518 | 1/20 | 0.53 |
| ▸ | GPR27 | Q9NS67 | 1/20 | 0.53 |
| ▸ | TMPRSS4 | Q9NRS4 | 7/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.43 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.43 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.43 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.42 |
| ▸ | RORC | P51449 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2358001 | 0.89 | NR3C2 (0.60) | NR3C2AVPR2GPR27 | |
| SCHEMBL1384146 | 0.86 | NR3C2 (0.59) | NR3C2AVPR2GPR27ALDH1A1LMNA | |
| SCHEMBL2545593 | 0.81 | GPR27 (0.50) | NR3C2AVPR2GPR27ALDH1A1LMNA | |
| SCHEMBL1382627 | 0.79 | NR3C2 (0.48) | NR3C2AVPR2GPR27ALDH1A1 | |
| SCHEMBL2541630 | 0.78 | F7 (0.43) | TMPRSS4ALDH1A1 | |
| SCHEMBL2359646 | 0.77 | NR4A2 (0.51) | TMPRSS4LMNA | |
| SCHEMBL30038582 | 0.76 | CFTR (0.46) | NR3C2 | |
| SCHEMBL2543239 | 0.76 | NR3C2 (0.83) | NR3C2AVPR2GPR27TMPRSS4ALDH1A1 | |
| SCHEMBL2359639 | 0.76 | NR3C2 (0.83) | NR3C2AVPR2GPR27TMPRSS4ALDH1A1 | |
| SCHEMBL1384488 | 0.73 | AVPR2 (0.45) | AVPR2GPR27ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2349997-B1 | ATROPISOMERS OF (HYDROXYALKYL) PYRROLE DERIVATIVES | EXELIXIS INC (US) | 2015-08-12 | — | — | EP | disclosed |
| US-8487117-B2 | Atropisomers of (hydroxyalkyl) pyrrole derivatives | EXELIXIS, INC. (US) | 2013-07-16 | — | — | US | disclosed |
| US-8487117-B2 | Atropisomers of (hydroxyalkyl) pyrrole derivatives | EXELIXIS, INC. (US) | 2013-07-16 | — | — | US | disclosed |
| US-8487117-B2 | Atropisomers of (hydroxyalkyl) pyrrole derivatives | EXELIXIS, INC. (US) | 2013-07-16 | — | — | US | disclosed |
| US-20110263673-A1 | Atropisomers of (Hydroxyalkyl) Pyrrole Derivatives | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2011-10-27 | — | — | US | disclosed |
| US-20110263673-A1 | Atropisomers of (Hydroxyalkyl) Pyrrole Derivatives | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2011-10-27 | — | — | US | disclosed |
| CN-102186817-A | Atropisomers of (hydroxyalkyl) pyrrole derivatives | EXELIXIS INC | 2011-09-14 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110263673-A1 | Atropisomers of (Hydroxyalkyl) Pyrrole Derivatives | ADRB3, HSD11B1, AKR1C3 | NR3C2 62/4885AVPR2 68/4885GPR27 1241/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.